Armata Pharmaceuticals, Inc.ARMPNYSE
Loading
Asset Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Percentile
P29
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
3 yr
Consecutive declineDecelerating
PeriodValue
2024-12.12%
2023-8.82%
202254.62%
202176.56%
202055.26%
2019114.11%
20186.72%
2017-38.79%
2016-42.23%
201510.05%